Replies to post #189347 on Biotech Values

[DewDiligence]

OCRX’s rise today may be related to the buyout of HPTX by HZNP (#msg-112225598). On the HZNP-HTPX CC this morning, it was stated that Raviciti will not advance to phase-3 in HE, so OCRX has one fewer competitor to worry about in this arena.

Please see the bottom of #msg-112183133 for related info.